Ignite Creation Date:
2024-05-06 @ 11:14 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03469167
Status:
COMPLETED
Last Update Posted:
2018-03-19
First Post:
2018-03-05
Brief Title:
Study to Evaluate Efficacy and Safety of Wound Dressing Solution Containing EGF in Patients With Peptic Ulcers Bleeding
Sponsor:
CGBio Inc
Organization:
CGBio Inc
Study Overview
Official Title:
Clinical Study to Evaluate Efficacy and Safety of CEGP003Wound Dressing Solution Containing EGF for Achieving Hemostasis and Protecting Ulcer in Patients With Acute Peptic Ulcer Bleeding A Prospective Randomized Trial
Status:
COMPLETED
Status Verified Date:
2018-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CEGP003
Brief Summary:
This is a prospective single-blinded randomized study to evaluate the efficacy and safety of CEGP003 in patients with acute peptic ulcers bleeding compared to endoscopic epinephrine injection therapy
Detailed Description:
CEGP003 is wound dressing solution containing Hydroxyethyl-cellulose and EGF Epidermal growth factor EGF stimulates cell growth and differentiation by binding to its receptor which can enhance wound healing and regeneration of new tissue finally may provide a new option in treating a peptic ulcers bleeding
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None